C3ORF31 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.42630351973594E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.42689998600321E-09 |
Normal-vs-Stage2 |
3.03420000002941E-06 |
Normal-vs-Stage3 |
1.62436730732907E-12 |
Normal-vs-Stage4 |
3.08169999962971E-07 |
Stage1-vs-Stage2 |
6.754400E-01 |
Stage1-vs-Stage3 |
3.17779999980949E-07 |
Stage1-vs-Stage4 |
2.563000E-01 |
Stage2-vs-Stage3 |
2.087700E-02 |
Stage2-vs-Stage4 |
5.759800E-01 |
Stage3-vs-Stage4 |
1.216400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.64512847788956E-12 |
Normal-vs-AfricanAmerican |
2.217600E-02 |
Normal-vs-Asian |
2.713200E-01 |
Caucasian-vs-AfricanAmerican |
6.26470000000268E-05 |
Caucasian-vs-Asian |
8.790200E-02 |
AfricanAmerican-vs-Asian |
9.301800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.9498183329888E-12 |
Normal-vs-Female |
1.81843429203354E-12 |
Male-vs-Female |
6.855600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.400200E-03 |
Normal-vs-Age(41-60Yrs) |
7.25209892138423E-11 |
Normal-vs-Age(61-80Yrs) |
2.65087951589749E-12 |
Normal-vs-Age(81-100Yrs) |
3.61549999938759E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.250600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.670200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.571800E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.591400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.838000E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.274200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.561400E-01 |
Normal-vs-Grade 2 |
3.3658997811159E-10 |
Normal-vs-Grade 3 |
1.62458935193399E-12 |
Normal-vs-Grade 4 |
4.13199999993452E-07 |
Grade 1-vs-Grade 2 |
9.884300E-03 |
Grade 1-vs-Grade 3 |
2.027700E-04 |
Grade 1-vs-Grade 4 |
3.078400E-02 |
Grade 2-vs-Grade 3 |
1.388070E-02 |
Grade 2-vs-Grade 4 |
2.806000E-01 |
Grade 3-vs-Grade 4 |
8.810600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.63646873829748E-12 |
Normal-vs-ccB subtype |
5.25000000139997E-08 |
ccA subtype-vs-ccB subtype |
9.517600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.55010013106016E-10 |
Normal-vs-N1 |
9.21529999975412E-07 |
N0-vs-N1 |
2.081200E-01 |
|
|